16 results
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
of innovative and scalable solutions, while overseeing strategy, sales, marketing, operations, engineering, and service efforts. Previously, at Zimmer Biomet
8-K
EX-99.1
diu16kobqm
15 Feb 22
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
9:26am
8-K
EX-99.1
mzqx7h0mlycu
9 Jun 21
Pulse Biosciences Announces Health Canada Approval for CellFX® System
8:22am
8-K
EX-99.1
fg2jis9p
25 Jan 21
Pulse Biosciences Announces CE Mark Approval for CellFX® System
8:12am
8-K
EX-99.1
j0xw9 e00
16 Mar 20
Pulse Biosciences Report Fourth Quarter and Full Year 2019 Financial Results
4:32pm
8-K
EX-99.1
8uujyd7zd8fw8
19 Mar 19
Pulse Biosciences Appoints Mitchell Levinson to Board of Directors
5:09pm
- Prev
- 1
- Next